BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ge K, Wang Y, Li P, Li M, Zhang W, Dan H, Hu X, Zhou J, Yang Q, Wang J, Song Z. Down-expression of the NLRP3 inflammasome delays the progression of diabetic retinopathy. Microvasc Res 2022;139:104265. [PMID: 34662588 DOI: 10.1016/j.mvr.2021.104265] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen M, Rong R, Xia X. Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases. J Neuroinflammation 2022;19:183. [PMID: 35836195 DOI: 10.1186/s12974-022-02547-2] [Reference Citation Analysis]
2 Williams BM, Cliff CL, Lee K, Squires PE, Hills CE. The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy. Front Physiol 2022;13:907504. [PMID: 35755447 DOI: 10.3389/fphys.2022.907504] [Reference Citation Analysis]
3 Cliff CL, Williams BM, Chadjichristos CE, Mouritzen U, Squires PE, Hills CE. Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes. Int J Mol Sci 2022;23:600. [PMID: 35054783 DOI: 10.3390/ijms23020600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Liu L, Jiang Y, Steinle JJ. PKA and Epac1 Reduce Nek7 to Block the NLRP3 Inflammasome Proteins in the Retinal Vasculature. Invest Ophthalmol Vis Sci 2022;63:14. [PMID: 35006270 DOI: 10.1167/iovs.63.1.14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]